35
https://pubmed.ncbi.nlm.nih.gov/38115616
This abstract discusses the role of abuse-deterrent formulations in managing opioid misuse in chronic pain management, and highlights the need for regulatory agencies to collaborate in defining policy and approving only abuse-deterrent opioid medications to address the global opioid crisis.